GB0911892D0 - Parathyroid hormone related protein antagonists - Google Patents

Parathyroid hormone related protein antagonists

Info

Publication number
GB0911892D0
GB0911892D0 GBGB0911892.8A GB0911892A GB0911892D0 GB 0911892 D0 GB0911892 D0 GB 0911892D0 GB 0911892 A GB0911892 A GB 0911892A GB 0911892 D0 GB0911892 D0 GB 0911892D0
Authority
GB
United Kingdom
Prior art keywords
related protein
parathyroid hormone
hormone related
protein antagonists
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0911892.8A
Other versions
GB2471693A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Complix NV
Original Assignee
Complix NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Complix NV filed Critical Complix NV
Priority to GB0911892A priority Critical patent/GB2471693A/en
Publication of GB0911892D0 publication Critical patent/GB0911892D0/en
Priority to PCT/EP2010/059713 priority patent/WO2011003935A1/en
Publication of GB2471693A publication Critical patent/GB2471693A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2318/00Antibody mimetics or scaffolds
    • C07K2318/20Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/635Parathyroid hormone (parathormone); Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0911892A 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists Withdrawn GB2471693A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0911892A GB2471693A (en) 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists
PCT/EP2010/059713 WO2011003935A1 (en) 2009-07-08 2010-07-07 Parathyroid hormone related protein antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0911892A GB2471693A (en) 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists

Publications (2)

Publication Number Publication Date
GB0911892D0 true GB0911892D0 (en) 2009-08-19
GB2471693A GB2471693A (en) 2011-01-12

Family

ID=41022368

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0911892A Withdrawn GB2471693A (en) 2009-07-08 2009-07-08 Parathyroid hormone related protein antagonists

Country Status (2)

Country Link
GB (1) GB2471693A (en)
WO (1) WO2011003935A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014016744A2 (en) 2012-01-06 2018-09-04 Complix Nv polypeptide, pharmaceutical composition and method for producing one or more polypeptides
DK2909233T3 (en) 2012-10-22 2017-02-20 Complix Nv Polypeptides that can internalize cellularly
AU2014229563B2 (en) 2013-03-15 2020-04-09 Fundacio Institut De Recerca Biomedica (Irb Barcelona) Method for the diagnosis, prognosis and treatment of cancer metastasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6172196A (en) * 1995-07-20 1997-02-18 Icn Pharmaceuticals Compounds and methods related to parathyroid hormone-like protein
AU2001252618A1 (en) * 2000-04-28 2001-11-12 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitors
US20080027006A1 (en) * 2004-02-12 2008-01-31 The Regents Of The University Of Colorado Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity
ATE538129T1 (en) * 2007-09-07 2012-01-15 Complix N V NON-NATURAL PROTEINOUS STRUCTURE COMPRISING THREE NON-COVALENTLY ASSOCIATE PEPTIDES
US11412930B2 (en) 2018-08-23 2022-08-16 Hi Llc Time-of-flight optical measurement and decoding of fast-optical signals

Also Published As

Publication number Publication date
GB2471693A (en) 2011-01-12
WO2011003935A9 (en) 2011-06-03
WO2011003935A1 (en) 2011-01-13
WO2011003935A4 (en) 2011-04-07

Similar Documents

Publication Publication Date Title
PL2406399T3 (en) Mirac proteins
ZA201300994B (en) Polypeptides
EP2555797A4 (en) Tnf- binding proteins
EP2649189A4 (en) Tnf- binding proteins
PL2927224T3 (en) Receptor antagonists
IL220161B (en) Oxyntomodulin peptide analogue
ZA201202266B (en) Insecticidal proteins
GB0915403D0 (en) Protein glycosylation
IL236236A (en) Fam26f polypeptide antibodies
GB0916749D0 (en) Peptide cleaning agents
EP2751136A4 (en) Natriuretic polypeptides
EP2480578A4 (en) Polypeptide modification
IL222000A0 (en) Arylsulfonamide ccr3 antagonists
GB201016494D0 (en) Polypeptide
IL215843A0 (en) Arylsulfonamide ccr3 antagonists
ZA201108446B (en) FViII-DERIVED PEPTIDES
EP2478001A4 (en) Advantageous mu-opiate receptor peptide compounds
IL240134A0 (en) Novel proteins
ZA201109283B (en) Protein
ZA201203722B (en) Peptide
GB0911892D0 (en) Parathyroid hormone related protein antagonists
GB0917685D0 (en) Antigenic polypeptide
TWI370607B (en) Vibrator
GB0910481D0 (en) Hormone fusion polypeptides
GB0909384D0 (en) Protein

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)